Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
Dasatinib + Quercetin Alzheimer's Disease (Phase 1/2) Tau, Other Combination, Small Molecule, Supplement, Dietary
E2814 Alzheimer's Disease (Phase 1/2) Eisai Co., Ltd. Tau Immunotherapy (passive)